1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Celiac Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Distension 1.2.3 Diarrhea 1.2.4 Anorexia 1.2.5 Others 1.3 Market by Application 1.3.1 Global Celiac Disease Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Celiac Disease Market Perspective (2016-2027) 2.2 Celiac Disease Growth Trends by Regions 2.2.1 Celiac Disease Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Celiac Disease Historic Market Share by Regions (2016-2021) 2.2.3 Celiac Disease Forecasted Market Size by Regions (2022-2027) 2.3 Celiac Disease Industry Dynamic 2.3.1 Celiac Disease Market Trends 2.3.2 Celiac Disease Market Drivers 2.3.3 Celiac Disease Market Challenges 2.3.4 Celiac Disease Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Celiac Disease Players by Revenue 3.1.1 Global Top Celiac Disease Players by Revenue (2016-2021) 3.1.2 Global Celiac Disease Revenue Market Share by Players (2016-2021) 3.2 Global Celiac Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Celiac Disease Revenue 3.4 Global Celiac Disease Market Concentration Ratio 3.4.1 Global Celiac Disease Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Revenue in 2020 3.5 Celiac Disease Key Players Head office and Area Served 3.6 Key Players Celiac Disease Product Solution and Service 3.7 Date of Enter into Celiac Disease Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Celiac Disease Breakdown Data by Type 4.1 Global Celiac Disease Historic Market Size by Type (2016-2021) 4.2 Global Celiac Disease Forecasted Market Size by Type (2022-2027) 5 Celiac Disease Breakdown Data by Application 5.1 Global Celiac Disease Historic Market Size by Application (2016-2021) 5.2 Global Celiac Disease Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Celiac Disease Market Size (2016-2027) 6.2 North America Celiac Disease Market Size by Type 6.2.1 North America Celiac Disease Market Size by Type (2016-2021) 6.2.2 North America Celiac Disease Market Size by Type (2022-2027) 6.2.3 North America Celiac Disease Market Size by Type (2016-2027) 6.3 North America Celiac Disease Market Size by Application 6.3.1 North America Celiac Disease Market Size by Application (2016-2021) 6.3.2 North America Celiac Disease Market Size by Application (2022-2027) 6.3.3 North America Celiac Disease Market Size by Application (2016-2027) 6.4 North America Celiac Disease Market Size by Country 6.4.1 North America Celiac Disease Market Size by Country (2016-2021) 6.4.2 North America Celiac Disease Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Celiac Disease Market Size (2016-2027) 7.2 Europe Celiac Disease Market Size by Type 7.2.1 Europe Celiac Disease Market Size by Type (2016-2021) 7.2.2 Europe Celiac Disease Market Size by Type (2022-2027) 7.2.3 Europe Celiac Disease Market Size by Type (2016-2027) 7.3 Europe Celiac Disease Market Size by Application 7.3.1 Europe Celiac Disease Market Size by Application (2016-2021) 7.3.2 Europe Celiac Disease Market Size by Application (2022-2027) 7.3.3 Europe Celiac Disease Market Size by Application (2016-2027) 7.4 Europe Celiac Disease Market Size by Country 7.4.1 Europe Celiac Disease Market Size by Country (2016-2021) 7.4.2 Europe Celiac Disease Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Celiac Disease Market Size (2016-2027) 8.2 Asia-Pacific Celiac Disease Market Size by Type 8.2.1 Asia-Pacific Celiac Disease Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Celiac Disease Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Celiac Disease Market Size by Type (2016-2027) 8.3 Asia-Pacific Celiac Disease Market Size by Application 8.3.1 Asia-Pacific Celiac Disease Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Celiac Disease Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Celiac Disease Market Size by Application (2016-2027) 8.4 Asia-Pacific Celiac Disease Market Size by Region 8.4.1 Asia-Pacific Celiac Disease Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Celiac Disease Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Celiac Disease Market Size (2016-2027) 9.2 Latin America Celiac Disease Market Size by Type 9.2.1 Latin America Celiac Disease Market Size by Type (2016-2021) 9.2.2 Latin America Celiac Disease Market Size by Type (2022-2027) 9.2.3 Latin America Celiac Disease Market Size by Type (2016-2027) 9.3 Latin America Celiac Disease Market Size by Application 9.3.1 Latin America Celiac Disease Market Size by Application (2016-2021) 9.3.2 Latin America Celiac Disease Market Size by Application (2022-2027) 9.3.3 Latin America Celiac Disease Market Size by Application (2016-2027) 9.4 Latin America Celiac Disease Market Size by Country 9.4.1 Latin America Celiac Disease Market Size by Country (2016-2021) 9.4.2 Latin America Celiac Disease Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Celiac Disease Market Size (2016-2027) 10.2 Middle East & Africa Celiac Disease Market Size by Type 10.2.1 Middle East & Africa Celiac Disease Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Celiac Disease Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Celiac Disease Market Size by Type (2016-2027) 10.3 Middle East & Africa Celiac Disease Market Size by Application 10.3.1 Middle East & Africa Celiac Disease Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Celiac Disease Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Celiac Disease Market Size by Application (2016-2027) 10.4 Middle East & Africa Celiac Disease Market Size by Country 10.4.1 Middle East & Africa Celiac Disease Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Celiac Disease Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Celiac Disease Introduction 11.1.4 Roche Revenue in Celiac Disease Business (2016-2021) 11.1.5 Roche Recent Development 11.2 Merck 11.2.1 Merck Company Details 11.2.2 Merck Business Overview 11.2.3 Merck Celiac Disease Introduction 11.2.4 Merck Revenue in Celiac Disease Business (2016-2021) 11.2.5 Merck Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Celiac Disease Introduction 11.3.4 Johnson & Johnson Revenue in Celiac Disease Business (2016-2021) 11.3.5 Johnson & Johnson Recent Development 11.4 BiolineRx 11.4.1 BiolineRx Company Details 11.4.2 BiolineRx Business Overview 11.4.3 BiolineRx Celiac Disease Introduction 11.4.4 BiolineRx Revenue in Celiac Disease Business (2016-2021) 11.4.5 BiolineRx Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Celiac Disease Introduction 11.5.4 Pfizer Revenue in Celiac Disease Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Innovate Biopharmaceuticals 11.6.1 Innovate Biopharmaceuticals Company Details 11.6.2 Innovate Biopharmaceuticals Business Overview 11.6.3 Innovate Biopharmaceuticals Celiac Disease Introduction 11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2016-2021) 11.6.5 Innovate Biopharmaceuticals Recent Development 11.7 ImmusanT 11.7.1 ImmusanT Company Details 11.7.2 ImmusanT Business Overview 11.7.3 ImmusanT Celiac Disease Introduction 11.7.4 ImmusanT Revenue in Celiac Disease Business (2016-2021) 11.7.5 ImmusanT Recent Development 11.8 Novartis 11.8.1 Novartis Company Details 11.8.2 Novartis Business Overview 11.8.3 Novartis Celiac Disease Introduction 11.8.4 Novartis Revenue in Celiac Disease Business (2016-2021) 11.8.5 Novartis Recent Development 11.9 Bristol-Myers Squibb 11.9.1 Bristol-Myers Squibb Company Details 11.9.2 Bristol-Myers Squibb Business Overview 11.9.3 Bristol-Myers Squibb Celiac Disease Introduction 11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Business (2016-2021) 11.9.5 Bristol-Myers Squibb Recent Development 11.10 Immunomedics 11.10.1 Immunomedics Company Details 11.10.2 Immunomedics Business Overview 11.10.3 Immunomedics Celiac Disease Introduction 11.10.4 Immunomedics Revenue in Celiac Disease Business (2016-2021) 11.10.5 Immunomedics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Celiac Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Distension Table 3. Key Players of Diarrhea Table 4. Key Players of Anorexia Table 5. Key Players of Others Table 6. Global Celiac Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Celiac Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Celiac Disease Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Celiac Disease Market Share by Regions (2016-2021) Table 10. Global Celiac Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Celiac Disease Market Share by Regions (2022-2027) Table 12. Celiac Disease Market Trends Table 13. Celiac Disease Market Drivers Table 14. Celiac Disease Market Challenges Table 15. Celiac Disease Market Restraints Table 16. Global Celiac Disease Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Celiac Disease Market Share by Players (2016-2021) Table 18. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Disease as of 2020) Table 19. Ranking of Global Top Celiac Disease Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Celiac Disease Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Celiac Disease Product Solution and Service Table 23. Date of Enter into Celiac Disease Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Celiac Disease Market Size by Type (2016-2021) (US$ Million) Table 26. Global Celiac Disease Revenue Market Share by Type (2016-2021) Table 27. Global Celiac Disease Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Celiac Disease Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Celiac Disease Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Celiac Disease Revenue Market Share by Application (2016-2021) Table 31. Global Celiac Disease Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Celiac Disease Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Celiac Disease Market Size by Type (2016-2021) (US$ Million) Table 34. North America Celiac Disease Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Celiac Disease Market Size by Application (2016-2021) (US$ Million) Table 36. North America Celiac Disease Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Celiac Disease Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Celiac Disease Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Celiac Disease Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Celiac Disease Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Celiac Disease Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Celiac Disease Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Celiac Disease Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Celiac Disease Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Celiac Disease Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Celiac Disease Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Celiac Disease Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Celiac Disease Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Celiac Disease Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Celiac Disease Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Celiac Disease Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Celiac Disease Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Celiac Disease Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Celiac Disease Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Celiac Disease Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Celiac Disease Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Celiac Disease Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Celiac Disease Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Celiac Disease Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Celiac Disease Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Celiac Disease Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Celiac Disease Market Size by Country (2022-2027) & (US$ Million) Table 63. Roche Company Details Table 64. Roche Business Overview Table 65. Roche Celiac Disease Product Table 66. Roche Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 67. Roche Recent Development Table 68. Merck Company Details Table 69. Merck Business Overview Table 70. Merck Celiac Disease Product Table 71. Merck Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 72. Merck Recent Development Table 73. Johnson & Johnson Company Details Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Celiac Disease Product Table 76. Johnson & Johnson Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 77. Johnson & Johnson Recent Development Table 78. BiolineRx Company Details Table 79. BiolineRx Business Overview Table 80. BiolineRx Celiac Disease Product Table 81. BiolineRx Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 82. BiolineRx Recent Development Table 83. Pfizer Company Details Table 84. Pfizer Business Overview Table 85. Pfizer Celiac Disease Product Table 86. Pfizer Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 87. Pfizer Recent Development Table 88. Innovate Biopharmaceuticals Company Details Table 89. Innovate Biopharmaceuticals Business Overview Table 90. Innovate Biopharmaceuticals Celiac Disease Product Table 91. Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 92. Innovate Biopharmaceuticals Recent Development Table 93. ImmusanT Company Details Table 94. ImmusanT Business Overview Table 95. ImmusanT Celiac Disease Product Table 96. ImmusanT Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 97. ImmusanT Recent Development Table 98. Novartis Company Details Table 99. Novartis Business Overview Table 100. Novartis Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 101. Novartis Recent Development Table 102. Bristol-Myers Squibb Company Details Table 103. Bristol-Myers Squibb Business Overview Table 104. Bristol-Myers Squibb Celiac Disease Product Table 105. Bristol-Myers Squibb Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 106. Bristol-Myers Squibb Recent Development Table 107. Immunomedics Company Details Table 108. Immunomedics Business Overview Table 109. Immunomedics Celiac Disease Product Table 110. Immunomedics Revenue in Celiac Disease Business (2016-2021) & (US$ Million) Table 111. Immunomedics Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Celiac Disease Market Share by Type: 2020 VS 2027 Figure 2. Distension Features Figure 3. Diarrhea Features Figure 4. Anorexia Features Figure 5. Others Features Figure 6. Global Celiac Disease Market Share by Application: 2020 VS 2027 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Celiac Disease Report Years Considered Figure 10. Global Celiac Disease Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Celiac Disease Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Celiac Disease Market Share by Regions: 2020 VS 2027 Figure 13. Global Celiac Disease Market Share by Regions (2022-2027) Figure 14. Global Celiac Disease Market Share by Players in 2020 Figure 15. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Disease as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Celiac Disease Revenue in 2020 Figure 17. Global Celiac Disease Revenue Market Share by Type (2016-2021) Figure 18. Global Celiac Disease Revenue Market Share by Type (2022-2027) Figure 19. North America Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Celiac Disease Market Share by Type (2016-2027) Figure 21. North America Celiac Disease Market Share by Application (2016-2027) Figure 22. North America Celiac Disease Market Share by Country (2016-2027) Figure 23. United States Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Celiac Disease Market Share by Type (2016-2027) Figure 27. Europe Celiac Disease Market Share by Application (2016-2027) Figure 28. Europe Celiac Disease Market Share by Country (2016-2027) Figure 29. Germany Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Celiac Disease Market Share by Type (2016-2027) Figure 37. Asia-Pacific Celiac Disease Market Share by Application (2016-2027) Figure 38. Asia-Pacific Celiac Disease Market Share by Region (2016-2027) Figure 39. China Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Celiac Disease Market Share by Type (2016-2027) Figure 47. Latin America Celiac Disease Market Share by Application (2016-2027) Figure 48. Latin America Celiac Disease Market Share by Country (2016-2027) Figure 49. Mexico Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Celiac Disease Market Share by Type (2016-2027) Figure 53. Middle East & Africa Celiac Disease Market Share by Application (2016-2027) Figure 54. Middle East & Africa Celiac Disease Market Share by Country (2016-2027) Figure 55. Turkey Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Roche Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 59. Merck Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 60. Johnson & Johnson Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 61. BiolineRx Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 62. Pfizer Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 63. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 64. ImmusanT Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 67. Immunomedics Revenue Growth Rate in Celiac Disease Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Roche Merck Johnson & Johnson BiolineRx Pfizer Innovate Biopharmaceuticals ImmusanT Novartis Bristol-Myers Squibb Immunomedics